← Back to all studies
gut microbiome diet

Esophageal cancer: from pathogenesis to precision therapies

15 April 2026

Zhang Shaosen, Shen Yanrong, Zhu Lingxuan, Lai Yancheng, Zhu Liang, Xiao Xinyi, Li Jiachen, Tan Wen, Lin Dongxin, Wu Chen

Summary

Here's a summary of the research study for a health-conscious reader: ### Plain-Language Summary This review synthesizes current knowledge on esophageal cancer (EC), a serious global health concern often diagnosed late. It explores how EC develops, its risk factors, and new approaches to detect and treat it, ultimately aiming to improve patient outcomes through earlier diagnosis and more personalized therapies. ### Key Findings * The study details established risk factors for EC and the step-by-step process of how normal cells transform into cancer. * It highlights the critical roles of molecular changes, including genetic mutations, epigenetic modifications, and the tumor's surrounding environment, in driving cancer initiation and progression. * The review explains how cancer cells evolve and become diverse through metabolic reprogramming and clonal expansion. * It summarizes advances in early screening techniques, prevention strategies, and minimally invasive interventions, especially for high-risk individuals. * Progress in precision treatments, such as targeted therapy and immunotherapy, is also discussed. ### Practical Takeaways for Nutrition and Longevity For those interested in nutrition and living a long, healthy life, understanding EC's risk factors is key: * **Maintain a Healthy Weight:** Obesity is a significant risk factor for esophageal adenocarcinoma (EAC). Prioritize a balanced diet and regular physical activity to achieve and maintain a healthy body weight. * **Limit Alcohol and Avoid Tobacco:** Excessive alcohol consumption and smoking are major risk factors for esophageal squamous-cell carcinoma (ESCC). Reducing or eliminating these habits is crucial for prevention. * **Prioritize a Nutrient-Rich Diet:** While not explicitly detailed in the abstract, a diet rich in fruits, vegetables, and whole grains, common recommendations for overall health and longevity, may contribute to reducing general cancer risk. * **Manage Chronic Reflux:** If you experience chronic acid reflux (GERD), work with your healthcare provider to manage it effectively, as it's a primary risk factor for EAC. ### Study Limitations This article is a review synthesizing existing research rather than presenting new findings or experimental data. Its conclusions are dependent on the scope, quality, and biases of the studies it analyzed.

Abstract

Esophageal cancer (EC), encompassing primarily esophageal squamous-cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), continues to pose a significant global health burden, which is largely due to delayed diagnosis and limited therapeutic efficacy. In this review, we synthesize current insights into key aspects of EC, including established risk factors, the stepwise process of tumorigenesis, strategies for early detection and prevention, and emerging therapeutic approaches. Emphasis is particularly placed on the molecular underpinnings of (1) early tumor initiation and malignant progression, with a focus on genetic mutations, epigenetic modifications, and alterations within the tumor microenvironment; (2) the clonal expansion and metabolic reprogramming that play essential roles in shaping the evolutionary trajectory of esophageal cancer, thereby promoting intratumoral heterogeneity; (3) the transition from normal epithelium to invasive carcinoma in both ESCC and EAC driven by sequential disruptions of molecular networks governing epithelial homeostasis; and (4) advances in early screening techniques and minimally invasive interventions that may offer new opportunities for EC prevention and early detection, especially in high-risk populations. In addition, we summarize recent progress in precision treatment, including chemotherapy, targeted therapy, immunotherapy, and multidisciplinary treatment. By delineating the molecular and cellular mechanisms underlying EC initiation and progression, this review aims to inform future directions in early diagnosis, risk stratification, and individualized therapy, ultimately contributing to improved clinical outcomes and precision prevention of EC.
Read Original Study →